Blood Collection In Healthy Adult Volunteers To Obtain Serum For Use In Serum Bactericidal Activity Assay Development
This study is currently recruiting participants.
Verified May 2013 by Pfizer
Sponsor:
Pfizer
Information provided by (Responsible Party):
Pfizer
ClinicalTrials.gov Identifier:
NCT00401232
First received: November 17, 2006
Last updated: May 14, 2013
Last verified: May 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This is a study to collect blood from volunteers to assist in assay development.
| Condition | Intervention | Phase |
|---|---|---|
|
Healthy Subjects |
Procedure: Blood Collection |
Phase 0 |
| Study Type: | Interventional |
| Study Design: | Allocation: Non-Randomized Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Diagnostic |
| Official Title: | Blood Collection in Healthy Adult Volunteers to Obtain Serum for Use in Serum Bactericidal Activity Assay Development |
Further study details as provided by Pfizer:
Primary Outcome Measures:
- "No outcome measures". Blood collected for assay development. [ Time Frame: 1 hour ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 900 |
| Study Start Date: | August 2006 |
| Estimated Study Completion Date: | December 2015 |
| Estimated Primary Completion Date: | December 2015 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| Arm 1 |
Procedure: Blood Collection
Blood Collection
|
Eligibility| Ages Eligible for Study: | 18 Years to 64 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Criteria
Inclusion Criteria:
- Healthy Volunteers aged 18-64
Exclusion Criteria:
- Bleeding disorder
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00401232
Contacts
| Contact: Pfizer CT.gov Call Center | 1-800-718-1021 |
Locations
| United States, Maryland | |
| Pfizer Investigational Site | Recruiting |
| Baltimore, Maryland, United States, 21201 | |
| United States, New Jersey | |
| Pfizer Investigational Site | Recruiting |
| Hackensack, New Jersey, United States, 07601 | |
Sponsors and Collaborators
Pfizer
Investigators
| Study Director: | Pfizer CT.gov Call Center | Pfizer |
More Information
Additional Information:
No publications provided
| Responsible Party: | Pfizer |
| ClinicalTrials.gov Identifier: | NCT00401232 History of Changes |
| Other Study ID Numbers: | 6108A1-800, B1971032 |
| Study First Received: | November 17, 2006 |
| Last Updated: | May 14, 2013 |
| Health Authority: | United States: Institutional Review Board |
ClinicalTrials.gov processed this record on May 19, 2013